The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wagner Klaus W. since 2021.
This trader's CIK number is 1766477.
At the time of last reporting, Wagner Klaus W. was the Chief Medical Officer of Inhibrx, Inc.. (stock ticker symbol INBX).
Also see all insider trading activities at Inhibrx, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | INBX | 0 | $0 | 176,033 | $4,300,094 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-17 | INBX | Sale | 19,559 | 25.29 | 494,647 |
| 2021-02-16 | INBX | Sale | 156,474 | 24.32 | 3,805,447 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wagner Klaus W. (Chief Medical Officer of Inhibrx, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.